Capital Advisors Inc Merck & Co., Inc. Transaction History

Capital Advisors Inc

$4.61 Billion
Q1 2024

A detailed history of Capital Advisors Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Capital Advisors Inc holds 7,315 shares of MRK stock, worth $934,271. This represents 0.02% of its overall portfolio holdings.

Number of Shares

7,315

Previous 7,000 4.5%

Holding current value

$934,271

Previous $763,000 26.47%

% of portfolio

0.02%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$113.24 - $131.95 $35,670 - $41,564	315 Added 4.5%	7,315 $965,000
Q4 2023 Jan 29, 2024	SELL	$100.18 - $109.02 $10,719 - $11,665	-107 Reduced 1.51%	7,000 $763,000
Q3 2023 Oct 24, 2023	SELL	$102.95 - $114.33 $4,220 - $4,687	-41 Reduced 0.57%	7,107 $731,000
Q2 2023 Jul 18, 2023	BUY	$108.61 - $118.38 $51,589 - $56,230	475 Added 7.12%	7,148 $824,000
Q1 2023 Apr 19, 2023	SELL	$102.94 - $114.86 $97,690 - $109,002	-949 Reduced 12.45%	6,673 $709,000

Q4 2022 Jan 17, 2023	SELL	$87.44 - $112.11 $5,333 - $6,838	-61 Reduced 0.79%	7,622 $0
Q3 2022 Oct 17, 2022	SELL	$84.53 - $94.96 $9,890 - $11,110	-117 Reduced 1.5%	7,683 $661,000
Q2 2022 Jul 15, 2022	SELL	$83.49 - $94.64 $80,233 - $90,949	-961 Reduced 10.97%	7,800 $711,000
Q1 2022 May 05, 2022	SELL	$73.51 - $82.4 $105,560 - $118,326	-1,436 Reduced 14.08%	8,761 $719,000
Q4 2021 Jan 27, 2022	BUY	$72.28 - $90.54 $253,558 - $317,614	3,508 Added 52.44%	10,197 $781,000
Q3 2021 Oct 25, 2021	SELL	$71.68 - $78.83 $430 - $472	-6 Reduced 0.09%	6,689 $502,000
Q2 2021 Aug 02, 2021	SELL	$70.31 - $77.77 $21,585 - $23,875	-307 Reduced 4.38%	6,695 $521,000
Q1 2021 May 25, 2021	BUY	$68.86 - $81.11 $32,570 - $38,365	473 Added 7.24%	7,002 $540,000
Q4 2020 Feb 08, 2021	BUY	$71.77 - $79.65 $26,698 - $29,629	372 Added 6.04%	6,529 $509,000
Q3 2020 Nov 02, 2020	BUY	$73.18 - $82.95 $17,270 - $19,576	236 Added 3.99%	6,157 $487,000
Q2 2020 Aug 07, 2020	BUY	$70.42 - $80.13 $15,069 - $17,147	214 Added 3.75%	5,921 $480,000
Q1 2020 May 21, 2020	BUY	$63.36 - $87.82 $8,173 - $11,328	129 Added 2.31%	5,707 $419,000
Q4 2019 Feb 04, 2020	SELL	$77.58 - $87.54 $122,886 - $138,663	-1,584 Reduced 22.12%	5,578 $484,000
Q2 2019 Aug 07, 2019	BUY	$69.84 - $81.59 $500,194 - $584,347	7,162 New	7,162 $0
Q1 2019 May 10, 2019	SELL	$69.58 - $79.36 $12.4 Million - $14.1 Million	-177,671 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$65.24 - $75.71 $796,710 - $924,570	12,212 Added 7.38%	177,671 $13 Million
Q3 2018 Nov 13, 2018	BUY	$57.69 - $67.84 $105,053 - $123,536	1,821 Added 1.11%	165,459 $11.7 Million
Q2 2018 Aug 06, 2018	SELL	$50.83 - $59.72 $167,027 - $196,239	-3,286 Reduced 1.97%	163,638 $0
Q1 2018 May 04, 2018	BUY	$50.96 - $59.23 $288,739 - $335,597	5,666 Added 3.51%	166,924 $0
Q4 2017 Jan 29, 2018	SELL	$51.62 - $61.64 $1.79 Million - $2.13 Million	-34,609 Reduced 17.67%	161,258 $9.07 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $703,981 - $757,496	11,999 Added 6.53%	195,867 $12.5 Million
Q2 2017 Aug 09, 2017	BUY	N/A	183,868	183,868 $11.8 Million

Others Institutions Holding MRK

# of Institutions

3,767

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $324B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors Inc with notifications on news.

Account

Capital Advisors Inc Merck & Co., Inc. Transaction History